SCP Personalized Medicine Management, LLCt – Trademark Portfolio

Entity Type: 16

SCP Personalized Medicine Management, LLCt holds 1 U.S. trademark filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 44 (Medical Services) — 1 filings in this category. Currently, 1 trademark is registered. Notable registered marks include CARE TO BE DIFFERENT. The owner is based in Austin, TX.

1515 S Capital of Texas Highway, Suite 400

Austin, TX 78746

1 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

Trademark Classifications

SCP Personalized Medicine Management, LLCt's trademark portfolio spans 1 Nice Classification class, reflecting the scope of goods and services protected under their brand portfolio.

44
Medical Services (1 filing)

Medical services; veterinary services; hygienic and beauty care for human beings or animals

Frequently Asked Questions

How many trademarks does SCP Personalized Medicine Management, LLCt have?

SCP Personalized Medicine Management, LLCt has 1 U.S. trademark filed with the USPTO. Of these, 1 registered.

What trademark classes does SCP Personalized Medicine Management, LLCt file in?

SCP Personalized Medicine Management, LLCt files trademarks across 1 Nice Classification class. The most active classes are Class 44 (Medical Services). Class 44 covers medical services; veterinary services; hygienic and beauty care for human beings or animals.

What are SCP Personalized Medicine Management, LLCt's most well-known trademarks?

SCP Personalized Medicine Management, LLCt's registered trademark portfolio includes well-known marks such as CARE TO BE DIFFERENT. These are among 1 currently registered trademark in the portfolio.

What is SCP Personalized Medicine Management, LLCt's trademark registration success rate?

SCP Personalized Medicine Management, LLCt has a 100% trademark registration rate, with 1 out of 1 resolved applications resulting in successful registration. Currently, 0 applications are pending review.